We found that MS-275 treatment of differentiated C2C12 myotubes improved PA-induced insulin resistance and inflammatory cytokine expression via the inhibition of JNK and nuclear factor-kappa B (NK-κB). This evidence concerns the gene MAPK8 and Insulin resistance.